-
Publication Venue For
-
Cord blood derived cell therapy product, DUOC-01, accelerates remyelination in a murine model of cuprizone induced demyelination.
17:S55-S55.
2015
-
Human cord blood derived CD14 cell therapy provides neuroprotection in aquired brain injury.
17:S57-S57.
2015
-
Neural engraftment of a cord blood-derived cell product following intrathecal transplantation.
17:S56-S56.
2015
-
The use of hydroxyethyl starch (HES) as a substitute for dextran 40 in the thaw and washing of HPC, apheresis products.
17:S60-S60.
2015
-
Cord blood for brain injury.
17:775-785.
2015
-
Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.
17:803-815.
2015
-
DUOC-01, A CANDIDATE CELL THERAPY PRODUCT DERIVED FROM BANKED CORD BLOOD, ACCELERATES BRAIN REMYELINATION IN NSG MICE FOLLOWING CUPRIZONE FEEDING.
16:S61-S62.
2014
-
Neuronal and glial cell composition in a mouse brain slice culture model is useful in developing human cord blood derived cellular therapies for neonatal hypoxic-ischemic brain injury.
16:S61-S61.
2014
-
PROTECTION OF BRAIN CELLS IN ORGANOTYPIC SLICE CULTURES EXPOSED TO OXYGEN AND GLUCOSE DEPRIVATION IS SPECIFICALLY MEDIATED BY CORD BLOOD CD14+CELLS.
16:S61-S61.
2014
-
Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases.
16:S16-S17.
2014
-
Tissue distribution of a cord blood-derived cell product following intrathecal transplantation.
16:S63-S63.
2014
-
Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34+
cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers.
16:1558-1574.
2014
-
Immune reconstitution after unrelated cord blood transplantation..
9:111-122.
2007
-
Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood..
9:569-576.
2007
-
Modification of a commercial cell sorter to support efficient and reliable preparation of ALDH-bright cells for clinical use..
9:562-568.
2007
-
AML-loaded DC generate Th1-type cellular immune responses in vitro..
8:95-104.
2006
-
Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
8:580-588.
2006
-
Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting..
7:126-133.
2005
-
A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation..
6:1-6.
2004
-
Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal..
6:328-336.
2004
-
Adipose-derived adult stem cells: isolation, characterization, and differentiation potential..
5:362-369.
2003
-
MANUFACTURING OF ALLOGENEIC HUMAN CORD TISSUE MESENCHYMAL STROMAL CELLS: INITIAL RESULTS OF A PHASE I CLINICAL TRIAL IN CHILDREN WITH AUTISM SPECTRUM DISORDER
2018
-
TARGETING NEUROINFLAMMATION WITH HUMAN UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS
2018
-
TOWARDS A MECHANISM-BASED POTENCY ASSAY FOR CORD BLOOD UNITS IN TREATMENT OF HYPOXIC-ISCHEMIC BRAIN DAMAGE
2018
-
CHARACTERIZATION OF MSC DERIVED FROM UMBILICAL CORD TISSUES
2017
-
UMBILICAL CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS INHIBIT LYSOPHOSPHATIDYLCHOLINE MEDIATED ACTIVATION OF MICROGLIA IN ORGANOTYPIC CEREBELLAR CULTURES
2017
-
Aldehyde dehydrogenase, but not viability of CD34 cells, predicts potency and engraftment after cord blood transplantation
2015
-
Experience in a public cord blood bank using a segment-based aldehyde dehydrogenase assay as a biomarker for umbilical cord blood potency
2014